INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/03/2026
Voltar para busca
Dado oficial do USPTO
IDS I20
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
12/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10
Data de depósito
23/10/2017
Data de registro
25/12/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/07/2025
Última transação
12/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
GB
Examinador
DELGIZZI, RONALD ERNEST
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the literal elements "IDS I20" represented in stylized font wherein the letters "IDS" and "I" appear in lower font in the color gray, and the dots over each letter "I" appear in red. The numbers "2" and "0" appear in gray.
Titulares e representantes
Titulares
Immunodiagnostic Systems Limited
Representantes
Kevan L. Morgan Seed IP Law Group LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use other than medical, namely, research or scientific investigation in the areas of immunochemistry, immunology, clinical chemistry, biochemistry, microbiology, hematology, and hemostasis; diagnostic test reagents, chemical and biochemical reagents, and preparations for determining the presence or concentration of an analyte for clinical, scientific or research purposes; diagnostic preparations for scientific or research use; assays and reagents for research purposes; biological and biochemical reagents, used for non-medical purposes, namely, for research and commercial use in the nature of biochemical or biological analysis
Classe 5
Reagents for use in diagnostic tests, namely, diagnostic kits comprised primarily of medical diagnostic reagents for testing of bodily fluids for use in disease detection, namely, diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry for medical purposes; chemical diagnostic reagents for medical use; diagnostic preparations, namely, diagnostic reagents for medical use; diagnostic testing materials, namely, immunoassays and chemistry tests for measuring analytes for use in diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry for medical use; reagents for use in diagnostic tests; chemical preparations for testing blood for use in disease detection, namely, diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry for medical purposes; diagnostic reagents for medical use for sale in kit form, namely diagnostic kits comprised primarily of medical diagnostic reagents for testing of bodily fluids for use in disease detection, namely, diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry
Classe 9
Instruments, namely, scientific instruments, namely, automated analyzers for testing and analyzing chemical and biological substances for the presence, absence or quantity of biological analytes or target chemicals, or instruments using automated detection methods for detecting and identifying chemical and biological substances, not for medical purposes, for testing, processing or detecting biological samples; computer software for use in analyzing and managing biological data
Classe 10
Medical diagnostic apparatus for medical purposes, namely, diagnostic instruments for medical use in immunoassay and clinical chemistry testing such as electromagnetic medical diagnostic imaging apparatus; medical diagnostic testing instruments for use in immunoassay medical procedures, namely, medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical diagnostic instruments, namely, medical instrument for cardiovascular diagnostics; blood testing apparatus
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
C71T
CANCELLED SECTION 71
11/07/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/04/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/04/2019
FIMP
FINAL DISPOSITION PROCESSED
09/04/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/03/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
25/12/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2018
PUBO
PUBLISHED FOR OPPOSITION
09/10/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/10/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/09/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/09/2018
ALIE
ASSIGNED TO LIE
04/09/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/07/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/07/2018
RFNT
REFUSAL PROCESSED BY IB
02/03/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/02/2018
RFRR
REFUSAL PROCESSED BY MPU
14/02/2018
MAFR
APPLICATION FILING RECEIPT MAILED
09/02/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2018
CNRT
NON-FINAL ACTION WRITTEN
07/02/2018
DOCK
ASSIGNED TO EXAMINER
05/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/02/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IDS I20 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.